IMR Stock Overview
A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Imricor Medical Systems, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$1.03 |
| 52 Week High | AU$1.38 |
| 52 Week Low | AU$0.41 |
| Beta | 0.19 |
| 1 Month Change | 9.04% |
| 3 Month Change | 84.68% |
| 1 Year Change | 81.42% |
| 3 Year Change | 0.49% |
| 5 Year Change | -10.87% |
| Change since IPO | -29.31% |
Recent News & Updates
Recent updates
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Imricor Medical Systems, Inc.'s (ASX:IMR) CEO For Now
May 08
Does Imricor Medical Systems (ASX:IMR) Have A Healthy Balance Sheet?
Jun 17Here's Why Imricor Medical Systems (ASX:IMR) Must Use Its Cash Wisely
Jul 08Will Imricor Medical Systems (ASX:IMR) Spend Its Cash Wisely?
Mar 23We're Hopeful That Imricor Medical Systems (ASX:IMR) Will Use Its Cash Wisely
May 09When Will Imricor Medical Systems, Inc. (ASX:IMR) Turn A Profit?
Feb 28We Think Imricor Medical Systems (ASX:IMR) Needs To Drive Business Growth Carefully
Jan 24What Is The Ownership Structure Like For Imricor Medical Systems, Inc. (ASX:IMR)?
Dec 02
What You Need To Know About Imricor Medical Systems, Inc.'s (ASX:IMR) Investor Composition
Aug 18Analysts Expect Breakeven For Imricor Medical Systems, Inc. (ASX:IMR)
Jun 25Shareholder Returns
| IMR | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | -4.7% | -0.4% | -2.0% |
| 1Y | 81.4% | 0.9% | 7.8% |
Return vs Industry: IMR exceeded the Australian Medical Equipment industry which returned 0.9% over the past year.
Return vs Market: IMR exceeded the Australian Market which returned 7.8% over the past year.
Price Volatility
| IMR volatility | |
|---|---|
| IMR Average Weekly Movement | 13.7% |
| Medical Equipment Industry Average Movement | 9.0% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in AU Market | 16.8% |
| 10% least volatile stocks in AU Market | 3.1% |
Stable Share Price: IMR's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: IMR's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | n/a | Steve Wedan | www.imricor.com |
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company’s principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning.
Imricor Medical Systems, Inc. Fundamentals Summary
| IMR fundamental statistics | |
|---|---|
| Market cap | AU$276.93m |
| Earnings (TTM) | -AU$32.54m |
| Revenue (TTM) | AU$1.32m |
209.2x
P/S Ratio-8.5x
P/E RatioIs IMR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IMR income statement (TTM) | |
|---|---|
| Revenue | US$824.32k |
| Cost of Revenue | US$1.74m |
| Gross Profit | -US$913.44k |
| Other Expenses | US$19.35m |
| Earnings | -US$20.26m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.075 |
| Gross Margin | -110.81% |
| Net Profit Margin | -2,458.30% |
| Debt/Equity Ratio | -126.8% |
How did IMR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 20:03 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Imricor Medical Systems, Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Elyse Shapiro | Bell Potter |
| Sarah Mann | MA Moelis Australia Securities Pty Ltd |
| Scott Power | Morgans Financial Limited |